UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Results of an International Randomized Phase III Trial of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus Versus Placebo to Control Metastatic Sarcomas in Patients After Benefit From Prior Chemotherapy

Journal of clinical oncology, 2013-07, Vol.31 (19), p.2485-2492

2013

Volltextzugriff (PDF)

Randomized Phase II Trial of Ridaforolimus in Advanced Endometrial Carcinoma

Journal of clinical oncology, 2015-11, Vol.33 (31), p.3576-3582

2015

Volltextzugriff (PDF)

Oral Ridaforolimus Plus Trastuzumab for Patients With HER2+ Trastuzumab-Refractory Metastatic Breast Cancer

Clinical breast cancer, 2015-02, Vol.15 (1), p.60-65

2015

Volltextzugriff (PDF)

Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

European journal of heart failure, 2020-12, Vol.22 (12), p.2272-2289

2020

Volltextzugriff (PDF)

Phase III, placebo-controlled trial (SUCCEED) evaluating ridaforolimus as maintenance therapy in advanced sarcoma patients following clinical benefit from prior standard cytotoxic chemotherapy: Long-term (≥ 24 months) overall survival results

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.10010-10010

2012

Volltextzugriff (PDF)

Intraperitoneal Chemotherapy With Cisplatin and Melphalan

JNCI : Journal of the National Cancer Institute, 1988-09, Vol.80 (14), p.1118-1124

1988

Volltextzugriff (PDF)

In vitro chemosensitivity of brain tumors to cisplatin and its analogues, iproplatin and carboplatin

Cancer chemotherapy and pharmacology, 1988, Vol.22 (1), p.80-82

1988

Volltextzugriff (PDF)

Comparative effect of cisplatin, spiroplatin, carboplatin and iproplatin in a human tumor clonogenic assay

Journal of cancer research and clinical oncology, 1990-01, Vol.116 (4), p.392-396

1990

Volltextzugriff (PDF)

Phase I study of Brequinar sodium (NSC 368390) in patients with solid malignancies

Cancer chemotherapy and pharmacology, 1990-01, Vol.25 (5), p.345-351

1990

Volltextzugriff (PDF)

Loss of fluorescence by anthracycline antibiotics: effects of xanthine oxidase and identification of the nonfluorescent metabolites

Cancer research (Chicago, Ill.), 1987-02, Vol.47 (4), p.1036-1039

1987

Volltextzugriff (PDF)

Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neck

Cancer, 1984-10, Vol.54 (8), p.1499-1503

1984

Volltextzugriff (PDF)

Metabolism and disposition of menogaril (NSC 269148) in the rabbit

Cancer research (Chicago, Ill.), 1985-11, Vol.45 (11), p.5352-5357

1985

Volltextzugriff (PDF)

Quantitation of differential sensitivity of normal marrow myeloid progenitor cells to anthracene derivatives

Investigational new drugs, 1986-01, Vol.4 (1), p.11-16

1986

Volltextzugriff (PDF)

Comparative murine metabolism and disposition of class II anthracycline antibiotics

Cancer chemotherapy and pharmacology, 1985-01, Vol.15 (2), p.153-160

1985

Volltextzugriff (PDF)

Validation of clinical predictive value of in vitro colorimetric chemosensitivity assay in head and neck cancer

European journal of cancer & clinical oncology, 1990, Vol.26 (7), p.834-838

1990

Volltextzugriff (PDF)

In vitro chemosensitivity testing of flavone acetic acid (LM975; NSC 347512) and its diethylaminoethyl ester derivative (LM985; NSC 293015)

European journal of cancer & clinical oncology, 1987-08, Vol.23 (8), p.1135-1139

1987

Volltextzugriff (PDF)

Clinical and pharmacokinetic phase I trial with the diethylaminoester of flavone acetic acid (LM985, NSC 293015)

European journal of cancer & clinical oncology, 1987-06, Vol.23 (6), p.837-842

1987

Volltextzugriff (PDF)

Phase II study of a combination of hydroxyurea, fluorouracil and mitomycin in previously treated squamous cell carcinoma of the head and neck

European journal of cancer & clinical oncology, 1986-03, Vol.22 (3), p.241-243

1986

Volltextzugriff (PDF)

Comparative effect of cisplatin, spiroplatin, carboplatin, iproplatin and JM40 in a human myeloid clonogenic assay

European journal of cancer & clinical oncology, 1988-08, Vol.24 (8), p.1309-1312

1988

Volltextzugriff (PDF)

Phase II trial of triglycidylurazol (TGU) in advanced malignant melanoma

European journal of cancer & clinical oncology, 1987-02, Vol.23 (2), p.251-252

1987

Volltextzugriff (PDF)

Phase I clinical trial with ametantrone (NSC-287513)

European journal of cancer & clinical oncology, 1981-07, Vol.17 (7), p.775-779

1981

Volltextzugriff (PDF)

Phase I clinical trial with alpha 1,3,5-triglycidyl- s-triazinetrione (NSC-296934)

European journal of cancer & clinical oncology, 1981-12, Vol.17 (12), p.1263-1266

1981

Volltextzugriff (PDF)

Primary resistance of renal adenocarcinoma to 1,2,4-triglycidylurazol (TGU, NSC 332488), a new triexpoxide cytostatic agent — A phase II study of the EORTC early clinical trials group

European journal of cancer & clinical oncology, 1986-06, Vol.22 (6), p.697-699

1986

Volltextzugriff (PDF)

Clinical phase I trial of marcellomycin with a single-dose schedule

European journal of cancer & clinical oncology, 1983-04, Vol.19 (4), p.449-454

1983

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Humans
(21)
Oncology
(19)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Antineoplastic Agents
(13)
Male
(13)
Pharmacology. Drug Treatments
(13)
Aged
(12)
Female
(12)
Adult
(11)
Middle Aged
(11)
Drug Evaluation
(9)
Chemotherapy
(7)
General Aspects
(6)
Neoplasms - Drug Therapy
(6)
Animals
(5)
Antineoplastic Agents - Therapeutic Use
(5)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Results of an International Randomized Phase III Trial of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus Versus Placebo to Control Metastatic Sarcomas in Patients After Benefit From Prior Chemotherapy

Randomized Phase II Trial of Ridaforolimus in Advanced Endometrial Carcinoma

Oral Ridaforolimus Plus Trastuzumab for Patients With HER2+ Trastuzumab-Refractory Metastatic Breast Cancer

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells

Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

Phase III, placebo-controlled trial (SUCCEED) evaluating ridaforolimus as maintenance therapy in advanced sarcoma patients following clinical benefit from prior standard cytotoxic chemotherapy: Long-term (≥ 24 months) overall survival results

Intraperitoneal Chemotherapy With Cisplatin and Melphalan

In vitro chemosensitivity of brain tumors to cisplatin and its analogues, iproplatin and carboplatin

Comparative effect of cisplatin, spiroplatin, carboplatin and iproplatin in a human tumor clonogenic assay

Phase I study of Brequinar sodium (NSC 368390) in patients with solid malignancies

Loss of fluorescence by anthracycline antibiotics: effects of xanthine oxidase and identification of the nonfluorescent metabolites

Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neck

Metabolism and disposition of menogaril (NSC 269148) in the rabbit

Quantitation of differential sensitivity of normal marrow myeloid progenitor cells to anthracene derivatives

Comparative murine metabolism and disposition of class II anthracycline antibiotics

Validation of clinical predictive value of in vitro colorimetric chemosensitivity assay in head and neck cancer

In vitro chemosensitivity testing of flavone acetic acid (LM975; NSC 347512) and its diethylaminoethyl ester derivative (LM985; NSC 293015)

Clinical and pharmacokinetic phase I trial with the diethylaminoester of flavone acetic acid (LM985, NSC 293015)

Phase II study of a combination of hydroxyurea, fluorouracil and mitomycin in previously treated squamous cell carcinoma of the head and neck

Comparative effect of cisplatin, spiroplatin, carboplatin, iproplatin and JM40 in a human myeloid clonogenic assay

Phase II trial of triglycidylurazol (TGU) in advanced malignant melanoma

Phase I clinical trial with ametantrone (NSC-287513)

Phase I clinical trial with alpha 1,3,5-triglycidyl- s-triazinetrione (NSC-296934)

Primary resistance of renal adenocarcinoma to 1,2,4-triglycidylurazol (TGU, NSC 332488), a new triexpoxide cytostatic agent — A phase II study of the EORTC early clinical trials group

Clinical phase I trial of marcellomycin with a single-dose schedule

Suchergebnisse filtern